Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up

[1]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[2]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[3]  Fabian J Theis,et al.  Body Fat Free Mass Is Associated with the Serum Metabolite Profile in a Population-Based Study , 2012, PloS one.

[4]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[5]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[6]  Yibin Wang,et al.  Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? , 2011, Cardiovascular research.

[7]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[8]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[9]  S. Kathiresan,et al.  Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.

[10]  F. Toledo,et al.  Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity , 2010, Obesity.

[11]  Guangju Zhai,et al.  Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis , 2010, Annals of the rheumatic diseases.

[12]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[13]  R. Holle,et al.  Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[14]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[15]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[16]  Ralph B D'Agostino,et al.  Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes care.

[17]  Peter Nowotny,et al.  Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. , 2002, Diabetes.

[18]  S. Haffner,et al.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.

[19]  P. Felig,et al.  Plasma amino acid levels and insulin secretion in obesity. , 1969, The New England journal of medicine.

[20]  F. Vaz,et al.  Acylcarnitines: reflecting or inflicting insulin resistance? , 2013, Diabetes.

[21]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.